Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
RANI · NASDAQ · Pharmaceutical Preparations
$0.5111−0.0695 (−11.97%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Rani Therapeutics Holdings (RANI) · oqro.io/stocks/RANI · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Insider trade · Traded Dec 13, 2024 · Filed Dec 16, 2024
Officer purchased ~$30K of RANI shares in the open marketSourceInsider trade · Traded Dec 9, 2024 · Filed Dec 10, 2024
CEO purchased ~$20K of RANI shares in the open marketSourceInsider trade · Traded Oct 15, 2024 · Filed Oct 17, 2024
10% owner sold ~$8.44M of RANI shares in the open marketSourceInsider trade · Traded Oct 15, 2024 · Filed Oct 17, 2024
10% owner sold ~$1.71M of RANI shares in the open marketSource